As of 2025-04-22, the Fair Value of Keros Therapeutics Inc (KROS) is -23.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.30 USD, the upside of Keros Therapeutics Inc is -261.51%.
With the market price of 14.30 USD and our fair value calculation, Keros Therapeutics Inc (KROS) is not a good investment. Investing in KROS stocks now will result in a potential loss of 261.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -45.36 | -58.74 | -104.68 | -152.99 | -187.35 | -109.82 |
| YoY growth | -267.59% | -29.50% | -78.21% | -46.15% | -22.46% | -88.78% |
| Market Cap (mil) | 580.01 |
| P/E | |
| Forward P/E |
| EPS | -4.62 |
| Avg earnings growth rate | -88.78% |
| TTM earnings | -187.35 |